{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:25:08Z","timestamp":1789057508091,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Josep Font Research Fellow Award, Hospital Clinic"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.semarthrit.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T00:12:19Z","timestamp":1436919139000},"page":"391-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies"],"prefix":"10.1016","volume":"45","author":[{"given":"Pilar","family":"Brito-Zer\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"P\u00e9rez-de-Lis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"P\u00e9rez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Fraile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Gheitasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Retamozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Bov\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Moncl\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ona","family":"Escoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"L\u00f3pez-Guillermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munther A.","family":"Khamashta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ramos-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2015.07.004_bib1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib2","first-page":"299","article-title":"Haemophagocytic syndromes in adults: current concepts and challenges ahead","volume":"135","author":"Emmenegger","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib3","first-page":"29","article-title":"Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society","volume":"18","author":"Henter","year":"1991","journal-title":"Semin Oncol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","article-title":"HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society","volume":"28","author":"Henter","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/BOR.0b013e32835b1366","article-title":"BIOGEAS study group. Biologics-induced autoimmune diseases","volume":"25","author":"Perez-Alvarez","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.amjmed.2010.11.028","article-title":"BIOGEAS Study Group. Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases","volume":"124","author":"Ramos-Casals","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","article-title":"BIOGEAS Study Group. Autoimmune diseases induced by biological agents: a double-edged sword?","volume":"9","author":"Ramos-Casals","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MD.0b013e318190f170","article-title":"BIOGEAS STUDY Group. A systematic review of the off-label use of biological therapies in systemic autoimmune diseases","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.critrevonc.2004.01.002","article-title":"Histiocyte disorders","volume":"50","author":"Henter","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/acr.20001","article-title":"A 21-year-old man with Still\u05f3s disease with fever, rash, and pancytopenia","volume":"62","author":"Mehta","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jbspin.2010.01.011","article-title":"Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with dalimumab","volume":"77","author":"Molt\u00f3","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00296-009-1204-0","article-title":"A rare trigger for macrophage activation syndrome","volume":"31","author":"Agarwal","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib14","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1086\/644731","article-title":"Fever, shock, and pancytopenia in a patient treated with alemtuzumab","volume":"49","author":"Bauer","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib15","first-page":"418","article-title":"Histoplasma capsulatum reactivation with haemophagocytic syndrome in a patient with chronic lymphocytic leukaemia","volume":"68","author":"van Koeveringe","year":"2010","journal-title":"Neth J Med"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrclinonc.2010.40-c1","article-title":"Alemtuzumab treatment for hemophagocytic lymphohistiocytosis","volume":"7","author":"Machaczka","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jbspin.2013.04.011","article-title":"Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still\u05f3s disease","volume":"80","author":"Banse","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00124743-200108000-00013","article-title":"Worsening of macrophage activation syndrome in a patient with adult onset Still\u05f3s disease after initiation of etanercept therapy","volume":"7","author":"Stern","year":"2001","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib19","first-page":"241","article-title":"Macrophage activation syndrome after etanercept treatment","volume":"34","author":"Sandhu","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ajh.21084","article-title":"Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still\u05f3s disease and concurrent macrophage activation syndrome","volume":"83","author":"Gianella","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib21","first-page":"443","article-title":"Macrophage activation syndrome induced by etanercept in a patient with systemic sclerosis","volume":"12","author":"Sterba","year":"2010","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib22","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1111\/j.1756-185X.2010.01544.x","article-title":"Exacerbation of adult-onset Still\u05f3s disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administration","volume":"13","author":"Kaneko","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib23","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2169\/internalmedicine.50.5430","article-title":"Etanercept-induced lupus accompanied by hemophagocytic syndrome","volume":"50","author":"Araki","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/rheumatology\/keg187","article-title":"Haemophagocytic syndrome in a rheumatoid arthritis patient treated with infliximab","volume":"42","author":"Aouba","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0755-4982(05)83984-3","article-title":"Macrophage activation syndrome after treatment with infliximab for fistulated Crohn\u05f3s disease","volume":"34","author":"Chauveau","year":"2005","journal-title":"Presse Med"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1086\/500262","article-title":"Cytomegalovirus ileitis and hemophagocytic syndrome associated with use of anti-tumor necrosis factor-alpha antibody","volume":"42","author":"Kohara","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MPG.0b013e31816a30b9","article-title":"Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab","volume":"47","author":"Francolla","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11096-010-9369-x","article-title":"Haemophagocytic syndrome and paradoxical reaction to tuberculostatics after treatment with infliximab","volume":"32","author":"Troncoso Mari\u00f1o","year":"2010","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib29","first-page":"449","article-title":"Tuberculosis associated with hemophagocytic syndrome complicated by treatment with infliximab","volume":"48","author":"Numakura","year":"2010","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib30","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.1002\/ibd.21828","article-title":"Severe CMV-related pneumonia complicated by the hemophagocytic lymphohistiocytic (HLH) syndrome in quiescent Crohn\u05f3s colitis: harmful cure?","volume":"17","author":"Presti","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib31","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2169\/internalmedicine.51.5687","article-title":"Hemophagocytic lymphohistiocytosis in a rheumatoid arthritis patient treated with infliximab","volume":"51","author":"Oda","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jbspin.2012.06.022","article-title":"Macrophage activation syndrome revealing disseminated tuberculosis in a patient on infliximab","volume":"80","author":"Andr\u00e9","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3816\/CLM.2008.n.052","article-title":"Epstein\u2013Barr virus-induced lymphoproliferative disorder after rituximab combined with CHOP therapy","volume":"8","author":"Johnston","year":"2008","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.medmal.2009.08.005","article-title":"Brucella bacteremia reactivation 70 years after the primary infection","volume":"40","author":"Meneses","year":"2010","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/s10165-009-0231-8","article-title":"Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus","volume":"20","author":"Kamiya","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib36","first-page":"326053","article-title":"A case of hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia after treatment with fludarabine, cyclophosphamide, and rituximab chemotherapy, with autopsy findings","author":"Tiong","year":"2012","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ard.2008.088179","article-title":"Tocilizumab for multirefractory adult-onset Still\u05f3s disease","volume":"68","author":"De Bandt","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/s10165-010-0348-9","article-title":"Benefit and a possible risk of tocilizumab therapy for adult-onset Still\u05f3s disease accompanied by macrophage-activation syndrome","volume":"21","author":"Kobayashi","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cyto.2012.02.006","article-title":"Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6","volume":"58","author":"Shimizu","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib40","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","article-title":"HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society","volume":"28","author":"Henter","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib42","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D","article-title":"Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo\u2013controlled trials","volume":"43","author":"Charles","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib43","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1002\/art.20617","article-title":"Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide","volume":"50","author":"Bingham","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib44","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.berh.2008.09.008","article-title":"Autoimmune diseases induced by TNF-targeted therapies","volume":"22","author":"Ramos-Casals","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11926-008-0072-z","article-title":"Vasculitis induced by tumor necrosis factor-targeted therapies","volume":"10","author":"Ramos-Casals","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.semarthrit.2007.08.003","article-title":"Drug-induced lupus due to anti-tumor necrosis factor alpha agents","volume":"37","author":"Costa","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.bor.0000198007.73320.6e","article-title":"Musculoskeletal manifestations and autoimmune diseases related to new biologic agents","volume":"18","author":"Haraoui","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib48","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.dld.2012.03.018","article-title":"Management of cytomegalovirus infection in inflammatory bowel diseases","volume":"44","author":"Pillet","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MAJ.0b013e31821ff728","article-title":"Viral infections in patients with inflammatory bowel disease on immunosuppressants","volume":"343","author":"Ali","year":"2012","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib50","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/apt.12305","article-title":"Systematic review: macrophage activation syndrome in inflammatory bowel disease","volume":"37","author":"Fries","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib51","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/imt.13.10","article-title":"Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature","volume":"5","author":"Jain","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.semarthrit.2015.07.004_bib53","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1473-3099(06)70524-2","article-title":"Tuberculosis-associated hemophagocytic syndrome","volume":"6","author":"Brastianos","year":"2006","journal-title":"Lancet Infect Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215001882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215001882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T02:53:17Z","timestamp":1652842397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017215001882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0049017215001882"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.07.004","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}